Nanomaterials and nanocomposites in healthcare and bioanalytical sciences

2^nd International Conference and Exhibition on Materials Science & Engineering

October 07-09, 2013 Hampton Inn Tropicana, Las Vegas, NV, USA

Sandeep Kumar Vashist

Accepted Abstracts: J Material Sci

Abstract :

During the last decade, there have been numerous advances in the production, characterization and use of nanomaterials (NMs) and nanocomposites (NCs) in healthcare and bioanalytical sciences. The most widely used NMs are graphene, carbon nanotubes, nanoparticles, quantum dots, chitosan, and dendrimers. The properties of NMs have been customized for specific applications by surface modification, functionalization or by developing nanocomposites with other nanomaterials and/ or polymers. They have been intensively used for a plethora of healthcare applications i.e., diagnostics, biosensors, assays, drug delivery, medicine, and therapeutics. Moreover, they have been employed for several bioanalytical applications such as water purification, food packaging, textiles, and environmental monitoring. However, despite the tremendous technology push and rapidly growing applications of NMs and NCs, there has been a significant lag in their commercialization. This is attributed mainly to the lack of international regulatory guidelines for evaluating the safety of NMs and NCs, the concerns about their toxicity and, the need for nanotechnology-based products to comply with healthcare and bioanalytical guidelines We provide an overview of our developed NMs and NCs-based healthcare and bioanalytical applications along with the challenges involved and the future prospects. Based on the significant advances and the intensive on-going research efforts, NMs and NCs will have a huge impact on the healthcare and bioanalytical sciences in the next decade.

Biography :

Sandeep K. Vashist completed his Ph.D. from Central Scientific Instruments Organisation, India in 2006. He was scientist at Bristol-Myers Squibb Company, Ireland (2006-2009), team leader at NUS Nanoscience and Nanotechnology Initiative, Singapore (2009-2012) and presently, the head of Immunodiagnostics at HSG-IMIT, Germany. His outputs include many technology transfers, patents and >100 publications in reputed journals and conferences. He has received prestigious fellowships and awards from renowned institutions for scientific excellence. He is executive editor of J Basic Appl Sci and J Pharma Bioanal Sci; editorial board member of J Nanomed Nanotech, and expert reviewer for many journals and funding agencies.